SCI
Stableford Capital II’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-5,642
| Closed | -$202K | – | 109 |
|
2023
Q2 | $202K | Sell |
5,642
-1,654
| -23% | -$59.1K | 0.09% | 106 |
|
2023
Q1 | $374K | Sell |
7,296
-13,348
| -65% | -$684K | 0.27% | 44 |
|
2022
Q4 | $999K | Sell |
20,644
-1,333
| -6% | -$64.5K | 0.54% | 34 |
|
2022
Q3 | $988K | Buy |
21,977
+1,733
| +9% | +$77.9K | 0.48% | 42 |
|
2022
Q2 | $997K | Sell |
20,244
-1,309
| -6% | -$64.5K | 0.46% | 42 |
|
2022
Q1 | $1.19M | Buy |
21,553
+30
| +0.1% | +$1.66K | 0.5% | 48 |
|
2021
Q4 | $1.11M | Sell |
21,523
-624
| -3% | -$32.2K | 0.47% | 53 |
|
2021
Q3 | $923K | Sell |
22,147
-1,646
| -7% | -$68.6K | 0.47% | 46 |
|
2021
Q2 | $932K | Buy |
23,793
+388
| +2% | +$15.2K | 0.45% | 54 |
|
2021
Q1 | $848K | Buy |
23,405
+241
| +1% | +$8.73K | 0.43% | 54 |
|
2020
Q4 | $853K | Buy |
23,164
+17,522
| +311% | +$645K | 0.5% | 48 |
|
2020
Q3 | $207K | Buy |
+5,642
| New | +$207K | 0.14% | 62 |
|
2020
Q1 | – | Sell |
-14,534
| Closed | -$569K | – | 95 |
|
2019
Q4 | $569K | Sell |
14,534
-396
| -3% | -$15.5K | 0.52% | 47 |
|
2019
Q3 | $536K | Buy |
14,930
+1,527
| +11% | +$54.8K | 0.5% | 44 |
|
2019
Q2 | $581K | Sell |
13,403
-1,298
| -9% | -$56.3K | 0.57% | 38 |
|
2019
Q1 | $624K | Sell |
14,701
-551
| -4% | -$23.4K | 0.52% | 48 |
|
2018
Q4 | $666K | Sell |
15,252
-1,450
| -9% | -$63.3K | 0.71% | 42 |
|
2018
Q3 | $736K | Sell |
16,702
-1,854
| -10% | -$81.7K | 0.49% | 46 |
|
2018
Q2 | $673K | Sell |
18,556
-91
| -0.5% | -$3.3K | 0.44% | 43 |
|
2018
Q1 | $662K | Buy |
18,647
+170
| +0.9% | +$6.04K | 0.47% | 42 |
|
2017
Q4 | $669K | Sell |
18,477
-27,613
| -60% | -$1,000K | 0.45% | 50 |
|
2017
Q3 | $1.65M | Buy |
46,090
+2,737
| +6% | +$97.7K | 1.19% | 25 |
|
2017
Q2 | $1.46M | Buy |
43,353
+5,730
| +15% | +$192K | 1.17% | 26 |
|
2017
Q1 | $1.29M | Buy |
37,623
+26,103
| +227% | +$893K | 1.12% | 25 |
|
2016
Q4 | $374K | Buy |
+11,520
| New | +$374K | 0.48% | 41 |
|